Related Experiment Video
Updated: Nov 1, 2025

A Heterotopic Mouse Model for Studying Laryngeal Transplantation
Published on: January 13, 2023
Benefiting Otolaryngology Patients with Biologics
1Consulting Editor, Otolaryngologic Clinics of North America, Past President, American Academy of Otolaryngology-Head and Neck Surgery, Secretary-Treasurer, American Otological Society, Partner, ENT & Allergy Associates, LLP, 18 East 48th Street, 2nd Floor, New York, NY 10017, USA; Clinical Professor, Department of Otolaryngology-, Head and Neck Surgery, Zucker School of Medicine at, Hofstra-Northwell, Hempstead, NY, USA; Clinical Associate Professor, Department of Otolaryngology-, Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
No abstract available in PubMed .
Related Concept Videos
Drug Products: Biologics, Biosimilars and Interchangeables
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Microorganisms in Medicine and Therapeutics
Tumor Immunotherapy
Biopharmaceutics and Pharmacokinetics: Overview

